Anabolic steroids in the prevention of sarcopenia in the elderly: a literature review

Authors

DOI:

https://doi.org/10.55892/jrg.v8i19.2713

Keywords:

Sarcopenia, Anabolic steroids, elderly, Muscle mass, Hormonal therapy

Abstract

Sarcopenia is characterized by the progressive loss of muscle mass, strength, and physical performance, representing a major public health concern due to the growing elderly population. Among the strategies investigated to mitigate its effects, the use of anabolic steroids emerges as a potential therapeutic approach capable of promoting increased muscle mass and functional improvement. This study aims to analyze, through a literature review, the effects of anabolic steroids on the prevention and treatment of sarcopenia in older adults, highlighting their mechanisms of action, benefits, and associated risks. National and international scientific databases were reviewed, prioritizing studies published in the last ten years. Findings indicate that although anabolic steroids may contribute to improved body composition and muscle strength, their use requires caution due to potential adverse effects, including cardiovascular, metabolic, and hormonal alterations. It is concluded that anabolic steroids may offer benefits in the prevention of sarcopenia when used under strict clinical supervision and with appropriate indication; however, further studies are needed to assess their long-term safety and effectiveness.

Downloads

Download data is not yet available.

Author Biographies

Cláudia Maria Muca de Araújo, Centro Universitário FAMETRO – Curso de Biomedicina

Graduando(a) em Biomedicina pela Faculdade Metropolitana de Manaus.

Kellem Natasha Campos Lima, Brasil Centro Universitário FAMETRO – Curso de Biomedicina

Graduando(a) em Biomedicina pela Faculdade Metropolitana de Manaus.

References

ALVES, A.; MERCADANTE, M. Sarcopenia e envelhecimento: definições, causas e intervenções terapêuticas. Revista Brasileira de Geriatria e Gerontologia, v. 21, n. 3, p. 345–356, 2018.

ANDRADE, F. et al. Terapias anabólicas no envelhecimento: revisão crítica dos benefícios e riscos. Journal of Aging Research, v. 14, n. 2, p. 112–120, 2019.

BATISTA, R. et al. Efeitos dos esteroides anabolizantes no músculo esquelético. Revista de Endocrinologia, v. 12, p. 77–85, 2020.

CRUZ-JENTOFT, A. et al. Sarcopenia: European consensus on definition and diagnosis. Age and Ageing, v. 48, n. 1, p. 16–31, 2019.

KELLER, K.; ENGELHARDT, M. Muscle loss in the elderly: current evidence and clinical implications. International Journal of Clinical Medicine, v. 6, p. 596–603, 2017.

MORAES, J.; SANTOS, L. Esteroides anabolizantes: mecanismos, efeitos e implicações clínicas. Revista de Ciências Médicas, v. 13, n. 4, p. 224–233, 2020.

PIEROTTI, A.; SILVA, R. Impacto da terapia hormonal na composição corporal de idosos. Geriatrics & Health, v. 9, p. 45–53, 2018.

SILVA, D.; FREITAS, P. Sarcopenia: etiologia, diagnóstico e manejo clínico. Journal of Aging Studies, v. 16, n. 3, p. 211–220, 2021.

TAVARES, R.; FONSECA, M. Exercícios resistidos como estratégia primordial na prevenção da sarcopenia. Revista de Ciências do Movimento Humano, v. 4, p. 34–41, 2020.

VASCONCELOS, P.; MORAIS, L. Riscos e benefícios dos esteroides anabolizantes: revisão integrativa. Revista Brasileira de Saúde e Envelhecimento, v. 7, p. 129–138, 2019.

Published

2025-11-21

How to Cite

ARAÚJO, C. M. M. de; LIMA, K. N. C. Anabolic steroids in the prevention of sarcopenia in the elderly: a literature review. JRG Journal of Academic Studies, Brasil, São Paulo, v. 8, n. 19, p. e082713, 2025. DOI: 10.55892/jrg.v8i19.2713. Disponível em: http://revistajrg.com/index.php/jrg/article/view/2713. Acesso em: 24 nov. 2025.

ARK